90-day mortality risk related to postoperative potassium levels in patients undergoing coronary bypass surgery

Mikkel Kjeldgaard1,2, Mads Odgaard Mæng1,2, Christian Torp-Pedersen3,4

  • 1Unit of Epidemiology and Biostatistics, Aalborg University Hospital, Søndre Skovvej 15, 9000 Aalborg, Denmark.

Insights

Post-coronary artery bypass grafting (CABG) potassium disturbances are rare but warrant monitoring. Both hyperkalemia and hypokalemia are linked to increased mortality risk, emphasizing careful evaluation of all potassium levels.

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Electrolyte depletion is recognized during coronary artery bypass grafting (CABG) with extracorporeal circulation.
  • Limited data exists on the incidence of potassium disturbances post-CABG and their association with mortality.

Purpose of the Study:

  • To investigate the frequency of potassium disturbances after on- and off-pump CABG.
  • To determine the association between plasma potassium levels and mortality risk in post-CABG patients.

Main Methods:

  • Analysis of 6123 adult patients undergoing first-time CABG from Danish National Registries (1995-2018).
  • Potassium levels measured within 14 days pre- and 7 days post-surgery, stratified into five intervals.
  • Cox proportional hazard models used to assess 90-day all-cause mortality risk.

Main Results:

  • Pre- and postoperative potassium disturbances were infrequent, but more prevalent in patients with chronic kidney disease.
  • Adjusted Cox regression showed a trend of increased mortality primarily in hyperkalemia.
  • Absolute mortality risk increased with hyperkalemia, hypokalemia, and low-normokalemia.

Conclusions:

  • While Cox regression indicated increased mortality mainly in hyperkalemia, absolute mortality risk data supports monitoring all potassium disturbances.
  • Careful evaluation of any potassium disturbance, including low-normal levels, is recommended post-CABG.
Abstract

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
899
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
443
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
96